P2X receptor activation protects in heart failure models. MRS2339 3, a 2-chloro-AMP derivative containing a (N)-methanocarba (bicyclo[3.1.0]hexane) system, activates this cardioprotective channel. Michaelis-Arbuzov and Wittig reactions provided phosphonate analogues of 3, expected to be stable in vivo due to the C-P bond. After chronic administration via a mini-osmotic pump (Alzet), some analogues significantly increased intact heart contractile function in calsequestrin-overexpressing mice (genetic model of heart failure) compared to vehicle-infused mice (all inactive at the vasodilatory P2Y(1) receptor). Two phosphonates, (1'S,2'R,3'S,4'R,5'S)-4'-(6-amino-2-chloropurin-9-yl)-2',3'-(dihydroxy)-1'-(phosphonomethylene)-bicyclo[3.1.0]hexane, 4 (MRS2775), and its homologue 9 (MRS2935), both 5'-saturated, containing a 2-Cl substitution, improved echocardiography-derived fractional shortening (20.25% and 19.26%, respectively, versus 13.78% in controls), while unsaturated 5'-extended phosphonates, all 2-H analogues, and a CH(3)-phosphonate were inactive. Thus, chronic administration of nucleotidase-resistant phosphonates conferred a beneficial effect, likely via cardiac P2X receptor activation. Thus, we have greatly expanded the range of carbocyclic nucleotide analogues that represent potential candidates for the treatment of heart failure.
class="Gene">P2X receptor activation protects in class="Chemical">an class="Disease">heart failure models. MRS2339 3, a 2-chloro-AMP derivative containing a (N)-methanocarba (bicyclo[3.1.0]hexane) system, activates this cardioprotective channel. Michaelis-Arbuzov and Wittig reactions provided phosphonate analogues of 3, expected to be stable in vivo due to the C-P bond. After chronic administration via a mini-osmotic pump (Alzet), some analogues significantly increased intact heart contractile function in calsequestrin-overexpressing mice (genetic model of heart failure) compared to vehicle-infused mice (all inactive at the vasodilatory P2Y(1) receptor). Two phosphonates, (1'S,2'R,3'S,4'R,5'S)-4'-(6-amino-2-chloropurin-9-yl)-2',3'-(dihydroxy)-1'-(phosphonomethylene)-bicyclo[3.1.0]hexane, 4 (MRS2775), and its homologue 9 (MRS2935), both 5'-saturated, containing a 2-Cl substitution, improved echocardiography-derived fractional shortening (20.25% and 19.26%, respectively, versus 13.78% in controls), while unsaturated 5'-extended phosphonates, all 2-H analogues, and a CH(3)-phosphonate were inactive. Thus, chronic administration of nucleotidase-resistant phosphonates conferred a beneficial effect, likely via cardiac P2X receptor activation. Thus, we have greatly expanded the range of carbocyclic nucleotide analogues that represent potential candidates for the treatment of heart failure.
Authors: R Gnana Ravi; Hak Sung Kim; Jörg Servos; Herbert Zimmermann; Kyeong Lee; Savitri Maddileti; José L Boyer; T Kendall Harden; Kenneth A Jacobson Journal: J Med Chem Date: 2002-05-09 Impact factor: 7.446
Authors: Xuenong Bo; Miran Kim; Stefania L Nori; Ralf Schoepfer; Geoffrey Burnstock; R Alan North Journal: Cell Tissue Res Date: 2003-07-04 Impact factor: 5.249
Authors: Y C Kim; S G Brown; T K Harden; J L Boyer; G Dubyak; B F King; G Burnstock; K A Jacobson Journal: J Med Chem Date: 2001-02-01 Impact factor: 7.446
Authors: Bin Xu; Andrew Stephens; Gary Kirschenheuter; Arthur F Greslin; Xiaoquin Cheng; Joe Sennelo; Marco Cattaneo; Maddalena L Zighetti; Aishe Chen; Soon-Ai Kim; Hak Sung Kim; Norbert Bischofberger; Gary Cook; Kenneth A Jacobson Journal: J Med Chem Date: 2002-12-19 Impact factor: 8.039
Authors: Jian-Bing Shen; Kiran S Toti; Saibal Chakraborty; T Santhosh Kumar; Chunxia Cronin; Bruce T Liang; Kenneth A Jacobson Journal: Purinergic Signal Date: 2020-01-27 Impact factor: 3.765
Authors: Sara Van Poecke; Matthew O Barrett; T Santhosh Kumar; Davy Sinnaeve; José C Martins; Kenneth A Jacobson; T Kendall Harden; Serge Van Calenbergh Journal: Bioorg Med Chem Date: 2012-02-15 Impact factor: 3.641
Authors: Joseph E Rittiner; Ilia Korboukh; Emily A Hull-Ryde; Jian Jin; William P Janzen; Stephen V Frye; Mark J Zylka Journal: J Biol Chem Date: 2012-01-03 Impact factor: 5.157
Authors: Thazha P Prakash; Walt F Lima; Heather M Murray; Wenyu Li; Garth A Kinberger; Alfred E Chappell; Hans Gaus; Punit P Seth; Balkrishen Bhat; Stanley T Crooke; Eric E Swayze Journal: Nucleic Acids Res Date: 2015-03-09 Impact factor: 16.971